Y, L., Y, X., C, G., Y, Z., J, Z., S, Z., . . . B, W. (2020). Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience. Dove Medical Press.
Cita Chicago Style (17a ed.)Y, Li, et al. Comparative Treatment Patterns and Outcomes of Fulvestrant Versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience. Dove Medical Press, 2020.
Cita MLA (8a ed.)Y, Li, et al. Comparative Treatment Patterns and Outcomes of Fulvestrant Versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience. Dove Medical Press, 2020.